from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2981c/ddlA

LFCtreatmentdescriptionclass of inhibitor

-0.872

Amikacinug/mL Amikacintranslation

-0.513

Cap5-10ug/mL Capreomycintranslation

-1.047

Rox10-50 ug/mL Roxithromycintranslation

-0.361

SM2-5 ug/mL Streptomycintranslation

0.360

Tet5-10 ug/mL Tetracyclinetranslation

0.467

Rif0.2-5ug/mL Rifampicintranscription

1.124

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.770

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.925

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.844

CPZ10-50 ug/mL Chlorpromazinerespiration

0.272

Clofazimine10-13 ug/mL Clofaziminerespiration

0.801

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.732

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.842

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.558

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.439

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.456

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.921

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.216

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.211

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.261

KCN5-20 ug/mL Potassium cyaniderespiration

0.267

NaN30.2-2 mM Sodium aziderespiration

0.386

Nigericin50 uM Nigericinrespiration

-0.859

TRC10-150 ug/mL Triclosanrespiration

-1.578

TRZ10-25 ug/mL Thioridazinerespiration

-0.468

Valinomycin0.5-10 uM Valinomycinrespiration

0.598

ZnSO42 mM ZnSO4respiration

0.104

menadione6-10 ug/mL Menadionerespiration

-0.409

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.746

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.859

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.926

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.479

NRP_1Non-replicating persistence stage 1dosRassociated

0.519

Amp0.2mg/mL AmpicillincellWall

0.432

Cephalexin20-100 ug/mL CephalexincellWall

-0.126

Cerulenin0.32-5 ug/mL CerulenincellWall

0.297

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.414

EMB10-20 ug/mL EthambutolcellWall

-0.008

Eta12-40 ug/mL EthionamidecellWall

0.432

INH0.2-0.4 ug/mL IsoniazidcellWall

0.025

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.464

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.834

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.434

BZA0.12 mg/mL BenzamidearomaticAmides

-0.138

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.087

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.226

H2O24 mM hydrogen peroxideDNAdamaging

0.861

Levo10 ug/mL LevofloxacinDNAdamaging

0.531

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.907

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.114

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.746

UVUV-irradiationDNAdamaging

-0.816

ARP41-4 ug/mL Antitubercular compound ARP4?

0.800

Antimycin12.5-50 ug/mL Antimycin A?

0.234

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.306

PA_110-50 ug/mL Antitubercular compound PA-1?

0.319

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.302

PA8240.2-2 ug/mL PA-824?

-1.063

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.054

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.371

Verapamil50 uM Verapamil?

0.691

mercaptoethanol2 mM 2-Mercaptoethanol?

0.468

methoxatin10-20 ug/mL Methoxatin?